Hsbc Holdings PLC Has $238.74 Million Stake in Stryker Co. (NYSE:SYK)

Hsbc Holdings PLC cut its position in Stryker Co. (NYSE:SYK - Free Report) by 20.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 662,902 shares of the medical technology company's stock after selling 170,101 shares during the quarter. Hsbc Holdings PLC owned about 0.17% of Stryker worth $238,742,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of SYK. SIH Partners LLLP acquired a new stake in shares of Stryker in the fourth quarter worth $1,080,000. Fayez Sarofim & Co boosted its position in shares of Stryker by 10.2% during the 4th quarter. Fayez Sarofim & Co now owns 2,380 shares of the medical technology company's stock valued at $857,000 after acquiring an additional 220 shares in the last quarter. J. Safra Sarasin Holding AG lifted its holdings in shares of Stryker by 66.6% during the fourth quarter. J. Safra Sarasin Holding AG now owns 2,497 shares of the medical technology company's stock valued at $899,000 after acquiring an additional 998 shares during the period. Stifel Financial Corp grew its position in Stryker by 2.5% during the 4th quarter. Stifel Financial Corp now owns 610,336 shares of the medical technology company's stock worth $219,760,000 after acquiring an additional 14,927 shares during the last quarter. Finally, OneDigital Investment Advisors LLC increased its holdings in shares of Stryker by 13.2% in the fourth quarter. OneDigital Investment Advisors LLC now owns 22,709 shares of the medical technology company's stock valued at $8,176,000 after purchasing an additional 2,641 shares in the last quarter. Institutional investors own 77.09% of the company's stock.

Analysts Set New Price Targets

SYK has been the subject of several research analyst reports. Argus set a $450.00 price target on shares of Stryker in a report on Monday, February 3rd. Needham & Company LLC reiterated a "buy" rating and set a $442.00 target price on shares of Stryker in a research report on Friday, March 21st. Stifel Nicolaus boosted their price target on Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Barclays lifted their target price on Stryker from $418.00 to $443.00 and gave the company an "overweight" rating in a research report on Monday, February 10th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $423.53.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the transaction, the director now directly owns 3,642,075 shares of the company's stock, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the business's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the sale, the director now owns 14,895 shares in the company, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.20% of the company's stock.

Stryker Stock Up 1.1 %

Shares of SYK stock traded up $3.83 during trading hours on Thursday, reaching $360.94. 1,349,722 shares of the stock were exchanged, compared to its average volume of 1,356,480. The firm has a market capitalization of $137.77 billion, a P/E ratio of 46.51, a P/E/G ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The business's fifty day moving average is $368.21 and its two-hundred day moving average is $373.06. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter last year, the firm earned $3.46 EPS. As a group, research analysts expect that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.93%. Stryker's dividend payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.